Developer docs
API playgroundTry for free, no card

Search company profiles

BioLM

Full company profile

uuid0006ynh

Namestring
BioLM
Legal namestring
Biolinguic Inc.
Websiteurl
biolm.ai
Company typeenum
Private
Founded yearint
2022
Descriptiontext

BioLM, operated by Biolinguic Inc., is a 2022-founded SaaS and professional services company providing an API-first biological AI platform for protein, antibody, and DNA modeling. The platform serves 50+ AI models — including ESM-2, AlphaFold2, ProGen2, AbLang-2, ESMFold, Boltz-2, ZymCTRL, and Evo — via GPU-backed REST APIs and a no-code BioLM Console with chat agents, a Python SDK with DuckDB-based caching, hosted JupyterLab notebooks, and a custom LLM finetuning pipeline supporting DeepSpeed/PB2/ASHA schedulers and hyperparameter optimization.

The company monetizes through tiered subscriptions (Starter at $0, Premium at $20/month, Professional at $350/month with finetuning, and a custom Enterprise tier offering on-premises deployment, priority support, and bespoke app development), supplemented by usage-based pay-per-second API billing that ranges from $0.000046/second for lightweight MPNN models to $0.004643/second for AlphaFold2. A separate Professional Services line delivers custom AI workflow development, fine-tuning, and wet-lab coordination to biotech clients lacking in-house ML capabilities. Distribution combines product-led self-serve onboarding (with $25 free credit upon sign-up) for individual researchers and SMB biotech teams with direct enterprise sales for services engagements.

Customer reach spans biotech and pharmaceutical companies (primary segment), academic researchers, and synthetic biology companies; named engagements include Caravel Bio (4x catalyst productivity improvement in under 2 months on enzyme temperature optimization) and Rhea's Factory (optimized enzyme sequence generation). The platform reports a user base of 1,000+ industry professionals and academics and has actively expanded its surface in 2025 through a production MCP server for AI-agent integrations (April 2025), a BioLM Community Slack (August 2025), and Kedro and Nextflow workflow integrations (September 2025).

Short descriptiontext

BioLM (Biolinguic Inc.) is a SaaS and professional services company that provides an API-first biological AI platform serving biotech firms, academics, and synthetic biology companies with 50+ GPU-backed protein, antibody, and DNA models, usage-based pricing, and custom workflow services.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersOakland, United States
HQ citystring
Oakland
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biological AI platform, protein engineering APIs, antibody design software, enzyme optimization AI, computational biology services
Industry3 codes
PRIMARYHLAAAIAE
AI/ML-Enabled Biologic Discovery Platforms (computational design, in silico screening)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAD
Bioinformatics & Multi-omics Analysis Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
NAICS code3 codes
  • Software Publishers513210
  • Computer Systems Design and Related Services54151
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Commercial Physical & Biological Research8731
Product category
Biological AI / Computational Biology Platform
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1API Platform Subscription
TypeSubscription Recurring
Description

Tiered subscription plans (Starter, Premium, Professional, Enterprise) providing API access to biological AI models with varying levels of API requests, model concurrency, and commercial usage rights.

biolm.ai:443
2Usage-Based API Billing
TypeUsage Based
Description

Pay-per-second pricing for individual model endpoints, with rates ranging from $0.000046/second (MPNN models) to $0.004643/second (AlphaFold2).

biolm.ai
3Professional Services
TypeProfessional Services
Description

Custom AI workflow development, model fine-tuning, and wet-lab coordination services for clients without in-house ML capabilities.

biolm.ai:443
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Infrastructure, Personnel, Marketing or Sales, Operations
Pricing details4 tiers
1Free tier for anyone looking to try the platform
ModelFreemiumBilling cadenceMonthly
Notes

$0/month; 2000/mo API requests; 10/sec rate limit; 24,000 lifetime API requests; 5 LTC lifetime units free; Access to all APIs, some Apps, all Chat Agents, and Jupyter Notebooks

biolm.ai
2For professionals and academics ramping up usage
ModelSubscriptionBilling cadenceMonthly
Notes

$20/month; 20,000/mo API requests included (0.1¢ per); Additional at 2¢ per; 15/sec rate limit; 5000/day API requests; Commercial use included; 99% uptime SLA

biolm.ai
3For finetuning and larger teams needing additional access
ModelSubscriptionBilling cadenceMonthly
Notes

$350/month; 500,000/mo API requests included (0.07¢ per); Unlimited/day API requests; 10/mo LTC units included; Finetune Protein Classifier, Protein Generator, DNA Classifier; 5 Finetuned Model Concurrency; Private API sharing with team; Share APIs publicly

biolm.ai
4Custom pricing for on-premises, priority support, and bespoke solutions
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Additional API requests; Option for On-Premises Cloud; Annual/Per-User Pricing; Support via Slack; Priority Feature Requests; Onboarding Period; We Finetune for You; Unlimited Finetuned Models; Consolidated Billing; Custom Model API Hosting; Bespoke App Development

biolm.ai
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

BioLM provides a GPU-backed biological AI platform delivered through a SaaS web console and REST API, offering access to 50+ protein, antibody, and DNA models (including ESM-2, AlphaFold2, ProGen2, AbLang-2) for sequence embeddings, structure prediction, molecule generation, and classification. The company bundles the platform with a Python SDK (biolmai) featuring DuckDB-based caching, no-code chat agents, an MCP server, hosted Jupyter notebooks, and tiered subscription/usage-based billing. BioLM also offers professional services for custom AI workflow development, fine-tuning, and end-to-end dry-lab to wet-lab validation for biotech clients.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 10°C improvement in optimal enzyme temperature in first library of <100 variants
+2 more records
Product overview1 text field

BioLM is a biological AI platform providing a cloud-based SaaS product (the BioLM Console) alongside a library of 50+ API models for protein, antibody, and DNA analysis. The platform is offered as a unified solution combining the BioLM Console (for no-code access via Chat Agents), a Python SDK for programmatic API access (with DuckDB-based caching for pipeline automation), LLM Finetuning capabilities for custom model training, and hosted Jupyter Notebooks. Professional Services and Partnering Services are offered as advisory and custom workflow offerings for biotech companies without in-house ML teams. The platform is backed by a cloud infrastructure of GPU-backed REST APIs with usage-based pricing across Starter, Premium, Professional, and Enterprise plan tiers.

Product and service7 records
1BioLM Platform / BioLM Console
CategoryBiological AI SaaS Platform
Description

Cloud-based SaaS platform providing GPU-backed APIs for protein, antibody, and DNA AI model predictions, embeddings, and generation. Used by 1,000+ industry professionals and academics for real-time molecule generation and model predictions.

2BioLM API Models
CategoryAI Model API Library
Description

Library of 50+ biological AI API models including ESM-2, AlphaFold2, ProGen2, AbLang-2, ABodyBuilder2, ESMFold, and others covering protein structure prediction, antibody engineering, enzyme optimization, DNA analysis, and generative protein design. Available via REST API with pay-per-second pricing.

3AI Chat Agents
CategoryNo-code AI Interface
Description

No-code chat agent interfaces for accessing transformer, diffusion, evolutionary, and bio-LLM models using natural language. Agents include ESMFold, ProGen2, ProteInfer, ESM-1v, and AbLang for protein structure prediction, generation, GO/EC prediction, masked amino acid prediction, and antibody restoration.

4BioLM Python SDK (biolmai)
CategoryDeveloper SDK
Description

Python client library (biolmai) providing programmatic access to BioLM's API models. Includes a DataPipeline module for orchestrating multi-step prediction workflows, DuckDB-based caching for deduplication and zero-cost re-querying, and integration with Kedro and Nextflow for workflow management.

5Professional Services
CategoryProfessional Services
Description

Custom AI workflow building, fine-tuning, and consulting for biotech companies. Includes lead optimization, candidate selection and in-silico screening, and closing the loop with wet-lab validation for enzyme and antibody projects. Offered for smaller biotech firms needing augmented ML expertise.

6Partnering Services
CategoryProfessional Services
Description

Royalty-free bio-AI expertise for companies without in-house ML. BioLM builds state-of-the-art models for industrial single-cell, protein, and DNA use-cases, including dry-lab to wet-lab experience, and determines the best AI plan-of-action tailored to client needs.

7Hosted JupyterLab Environment
CategoryDeveloper Environment
Description

Hosted JupyterLab environment (jupyter.biolm.ai) providing interactive tutorials and notebooks for using BioLM's models and SDKs, including guides for ESMFold, ProGen2, ESM-1v deep mutational scanning, and antibody engineering workflows.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Insitro combines ML with high-throughput biology for drug discovery — overlapping BioLM's AI-for-biology thesis but with substantially larger capital and an internal therapeutics pipeline.

TypeBroad incumbent
Description

Benchling is a leading cloud-based lab informatics platform serving biotech R&D teams; while not a model API, it competes for the same biotech IT budget and increasingly embeds AI/ML capabilities for biological data.

TypeBroad incumbent
Description

Schrödinger provides computational chemistry and biology software (including LiveDesign) used by pharma for molecular design, broadly overlapping BioLM's biotech customer base and predictive modeling capabilities.

TypeDirect peer
Description

Profluent develops frontier protein language models and provides API access for protein generation and engineering, positioning it as a near-direct competitor to BioLM's ProGen2/ESM-2 model catalog and developer-first GTM.

TypeBroad incumbent
Description

Generate Biomedicines operates a generative biology platform (Chroma) for protein design with internal pipeline assets; it competes with BioLM's generative protein and antibody design offerings while also pursuing internal therapeutics.

TypeEmerging player
Description

Absci offers AI-driven generative antibody design and wet-lab validation; it overlaps BioLM's antibody engineering (AbLang, ABodyBuilder) and wet-lab feedback loop offerings with an emerging platform play.

TypeBroad incumbent
Description

Recursion operates a techbio platform using AI and high-throughput wet-lab experimentation, overlapping BioLM's combined dry-/wet-lab value proposition though at much greater scale and capital intensity.

TypeDirect peer
Description

EvolutionaryScale builds large genomic/protein language models (ESM, Evo) and exposes them via API — a direct rival in the foundation-model-for-biology space that BioLM also serves.

TypeDirect peer
Description

Cradle offers a bio-AI platform for protein engineering with API/web access to generative and predictive models, directly overlapping BioLM's protein design and lead optimization use cases for biotech customers.

TypeBroad incumbent
Description

Valo Health uses AI across the drug discovery continuum with an integrated wet-lab component, broadly comparable to BioLM's end-to-end AI-to-wet-lab approach but focused on internal pipeline development.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration8 records

Each record includes

Title, Type, Description, Source

AI capability8 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BioLM

Biological AI / Computational Biology Platformbiolm.ai

BioLM (Biolinguic Inc.) is a SaaS and professional services company that provides an API-first biological AI platform serving biotech firms, academics, and synthetic biology companies with 50+ GPU-backed protein, antibody, and DNA models, usage-based pricing, and custom workflow services.

What BioLM does

BioLM, operated by Biolinguic Inc., is a 2022-founded SaaS and professional services company providing an API-first biological AI platform for protein, antibody, and DNA modeling. The platform serves 50+ AI models — including ESM-2, AlphaFold2, ProGen2, AbLang-2, ESMFold, Boltz-2, ZymCTRL, and Evo — via GPU-backed REST APIs and a no-code BioLM Console with chat agents, a Python SDK with DuckDB-based caching, hosted JupyterLab notebooks, and a custom LLM finetuning pipeline supporting DeepSpeed/PB2/ASHA schedulers and hyperparameter optimization.

The company monetizes through tiered subscriptions (Starter at $0, Premium at $20/month, Professional at $350/month with finetuning, and a custom Enterprise tier offering on-premises deployment, priority support, and bespoke app development), supplemented by usage-based pay-per-second API billing that ranges from $0.000046/second for lightweight MPNN models to $0.004643/second for AlphaFold2. A separate Professional Services line delivers custom AI workflow development, fine-tuning, and wet-lab coordination to biotech clients lacking in-house ML capabilities. Distribution combines product-led self-serve onboarding (with $25 free credit upon sign-up) for individual researchers and SMB biotech teams with direct enterprise sales for services engagements.

Customer reach spans biotech and pharmaceutical companies (primary segment), academic researchers, and synthetic biology companies; named engagements include Caravel Bio (4x catalyst productivity improvement in under 2 months on enzyme temperature optimization) and Rhea's Factory (optimized enzyme sequence generation). The platform reports a user base of 1,000+ industry professionals and academics and has actively expanded its surface in 2025 through a production MCP server for AI-agent integrations (April 2025), a BioLM Community Slack (August 2025), and Kedro and Nextflow workflow integrations (September 2025).

BioLM firmographics

Firmographics
Name
BioLM
Legal name
Biolinguic Inc.
Website
https://biolm.ai
Company type
Private
Founded year
2022
Operating status
Operating
Headcount range
1–10 employees
Short description
BioLM (Biolinguic Inc.) is a SaaS and professional services company that provides an API-first biological AI platform serving biotech firms, academics, and synthetic biology companies with 50+ GPU-backed protein, antibody, and DNA models, usage-based pricing, and custom workflow services.
Ownership category
akta.pro rank

BioLM industry classification

Industry
Product category
Biological AI / Computational Biology Platform
NAICS
Software Publishers (513210), Computer Systems Design and Related Services (54151), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Prepackaged Software (7372), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAAAIAE
AI/ML-Enabled Biologic Discovery Platforms (computational design, in silico screening)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAD
Bioinformatics & Multi-omics Analysis Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

Keywords

  • Biological AI platform
  • Protein engineering APIs
  • Antibody design software
  • Enzyme optimization AI
  • Computational biology services

Where BioLM is headquartered

Location

Headquarters

HQ city
Oakland
HQ country
United States
HQ region
North America

Offices1 record

Markets served

BioLM business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Infrastructure, Personnel, Marketing or Sales, Operations

Revenue model

  1. API Platform Subscription: Tiered subscription plans (Starter, Premium, Professional, Enterprise) providing API access to biological AI models with varying levels of API requests, model concurrency, and commercial usage rights.
  2. Usage-Based API Billing: Pay-per-second pricing for individual model endpoints, with rates ranging from $0.000046/second (MPNN models) to $0.004643/second (AlphaFold2).
  3. Professional Services: Custom AI workflow development, model fine-tuning, and wet-lab coordination services for clients without in-house ML capabilities.

Pricing tiers

ModelBillingPrice
FreemiumMonthlyFree tier for anyone looking to try the platform
SubscriptionMonthlyFor professionals and academics ramping up usage
SubscriptionMonthlyFor finetuning and larger teams needing additional access
SubscriptionMulti-year contractCustom pricing for on-premises, priority support, and bespoke solutions

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

BioLM product offering

Product offering

Core offering

BioLM provides a GPU-backed biological AI platform delivered through a SaaS web console and REST API, offering access to 50+ protein, antibody, and DNA models (including ESM-2, AlphaFold2, ProGen2, AbLang-2) for sequence embeddings, structure prediction, molecule generation, and classification. The company bundles the platform with a Python SDK (biolmai) featuring DuckDB-based caching, no-code chat agents, an MCP server, hosted Jupyter notebooks, and tiered subscription/usage-based billing. BioLM also offers professional services for custom AI workflow development, fine-tuning, and end-to-end dry-lab to wet-lab validation for biotech clients.

Product overview

BioLM is a biological AI platform providing a cloud-based SaaS product (the BioLM Console) alongside a library of 50+ API models for protein, antibody, and DNA analysis. The platform is offered as a unified solution combining the BioLM Console (for no-code access via Chat Agents), a Python SDK for programmatic API access (with DuckDB-based caching for pipeline automation), LLM Finetuning capabilities for custom model training, and hosted Jupyter Notebooks. Professional Services and Partnering Services are offered as advisory and custom workflow offerings for biotech companies without in-house ML teams. The platform is backed by a cloud infrastructure of GPU-backed REST APIs with usage-based pricing across Starter, Premium, Professional, and Enterprise plan tiers.

Differentiator

Problem solved

Functional benefit

Products and services

  • BioLM Platform / BioLM Console Cloud-based SaaS platform providing GPU-backed APIs for protein, antibody, and DNA AI model predictions, embeddings, and generation. Used by 1,000+ industry professionals and academics for real-time molecule generation and model predictions.
  • BioLM API Models Library of 50+ biological AI API models including ESM-2, AlphaFold2, ProGen2, AbLang-2, ABodyBuilder2, ESMFold, and others covering protein structure prediction, antibody engineering, enzyme optimization, DNA analysis, and generative protein design. Available via REST API with pay-per-second pricing.
  • AI Chat Agents No-code chat agent interfaces for accessing transformer, diffusion, evolutionary, and bio-LLM models using natural language. Agents include ESMFold, ProGen2, ProteInfer, ESM-1v, and AbLang for protein structure prediction, generation, GO/EC prediction, masked amino acid prediction, and antibody restoration.
  • BioLM Python SDK (biolmai) Python client library (biolmai) providing programmatic access to BioLM's API models. Includes a DataPipeline module for orchestrating multi-step prediction workflows, DuckDB-based caching for deduplication and zero-cost re-querying, and integration with Kedro and Nextflow for workflow management.
  • Professional Services Custom AI workflow building, fine-tuning, and consulting for biotech companies. Includes lead optimization, candidate selection and in-silico screening, and closing the loop with wet-lab validation for enzyme and antibody projects. Offered for smaller biotech firms needing augmented ML expertise.
  • Partnering Services Royalty-free bio-AI expertise for companies without in-house ML. BioLM builds state-of-the-art models for industrial single-cell, protein, and DNA use-cases, including dry-lab to wet-lab experience, and determines the best AI plan-of-action tailored to client needs.
  • Hosted JupyterLab Environment Hosted JupyterLab environment (jupyter.biolm.ai) providing interactive tutorials and notebooks for using BioLM's models and SDKs, including guides for ESMFold, ProGen2, ESM-1v deep mutational scanning, and antibody engineering workflows.

Quantifiable outcome

  • 10°C improvement in optimal enzyme temperature in first library of <100 variants
  • +2 more outcomes

Companies that use BioLM

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles3 records

BioLM technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration8 records

AI capability8 records

Feature6 records

BioLM partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

BioLM competitors and assessment

Company assessment

Broad incumbents

  • Insitro: Insitro combines ML with high-throughput biology for drug discovery — overlapping BioLM's AI-for-biology thesis but with substantially larger capital and an internal therapeutics pipeline.
  • Benchling: Benchling is a leading cloud-based lab informatics platform serving biotech R&D teams; while not a model API, it competes for the same biotech IT budget and increasingly embeds AI/ML capabilities for biological data.
  • Schrödinger: Schrödinger provides computational chemistry and biology software (including LiveDesign) used by pharma for molecular design, broadly overlapping BioLM's biotech customer base and predictive modeling capabilities.
  • Generate Biomedicines: Generate Biomedicines operates a generative biology platform (Chroma) for protein design with internal pipeline assets; it competes with BioLM's generative protein and antibody design offerings while also pursuing internal therapeutics.
  • Recursion: Recursion operates a techbio platform using AI and high-throughput wet-lab experimentation, overlapping BioLM's combined dry-/wet-lab value proposition though at much greater scale and capital intensity.
  • Valo Health: Valo Health uses AI across the drug discovery continuum with an integrated wet-lab component, broadly comparable to BioLM's end-to-end AI-to-wet-lab approach but focused on internal pipeline development.

Direct peers

  • Profluent Bio: Profluent develops frontier protein language models and provides API access for protein generation and engineering, positioning it as a near-direct competitor to BioLM's ProGen2/ESM-2 model catalog and developer-first GTM.
  • EvolutionaryScale: EvolutionaryScale builds large genomic/protein language models (ESM, Evo) and exposes them via API — a direct rival in the foundation-model-for-biology space that BioLM also serves.
  • Cradle: Cradle offers a bio-AI platform for protein engineering with API/web access to generative and predictive models, directly overlapping BioLM's protein design and lead optimization use cases for biotech customers.

Emerging players

  • Absci: Absci offers AI-driven generative antibody design and wet-lab validation; it overlaps BioLM's antibody engineering (AbLang, ABodyBuilder) and wet-lab feedback loop offerings with an emerging platform play.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

BioLM social profiles

Digital presence

BioLM financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BioLM leadership team

Management profile

Number of profiles

Profiles4 records

BioLM funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BioLM M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioLM

What does BioLM do?

BioLM provides a GPU-backed biological AI platform delivered through a SaaS web console and REST API, offering access to 50+ protein, antibody, and DNA models (including ESM-2, AlphaFold2, ProGen2, AbLang-2) for sequence embeddings, structure prediction, molecule generation, and classification. The company bundles the platform with a Python SDK (biolmai) featuring DuckDB-based caching, no-code chat agents, an MCP server, hosted Jupyter notebooks, and tiered subscription/usage-based billing. BioLM also offers professional services for custom AI workflow development, fine-tuning, and end-to-end dry-lab to wet-lab validation for biotech clients.

Is BioLM a public or private company?

BioLM is a private company. It is classified as venture growth investor backed and is currently operating.

When was BioLM founded?

BioLM was founded in 2022. It employs 1 to 10 people.

Where is BioLM based?

BioLM is headquartered in Oakland, United States, in the North America region.

How does BioLM make money?

Three revenue lines are on record. API Platform Subscription is the primary driver. The others are usage-Based API Billing and professional Services.

Who are BioLM's main competitors?

Broad incumbents on record are Insitro, Benchling, Schrödinger, Generate Biomedicines, Recursion and Valo Health. Direct peers are Profluent Bio, EvolutionaryScale and Cradle. Absci is listed as an emerging player.

Does BioLM have an API?

Yes. BioLM provides a REST API for protein, antibody, and DNA AI model predictions, embeddings, and generation. The API supports HTTP POST requests with token-based authentication and provides real-time model predictions. A Python SDK is offered. Billing is usage-based (pay-per-second). Models are served via GPU-backed infrastructure. Developer documentation is at api.biolm.ai.

What industry is BioLM in?

BioLM's product category is Biological AI / Computational Biology Platform. Its primary akta.pro industry code is HLAAAIAE, AI/ML-Enabled Biologic Discovery Platforms (computational design, in silico screening), with a secondary code of HLAGAJAO, AI/ML Platforms for Drug Discovery & Experiment Optimization. Its NAICS code is 513210 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales